PharmaShots Weekly Snapshot (September 23-27, 2019)

Share this

PharmaShots Weekly Snapshot (September 23-27, 2019)

1. Incyte Reports Updated Results of Pemigatinib in P-II FIGHT-202 Trial for Patients with Previously Treated Advanced Cholangiocarcinoma

Published: Sept 27, 2019 | Tags: Incyte, Reports, Updated, Results, Pemigatinib, P-II, FIGHT-202 Trial, Patients, Previously, Treated, Advanced, Cholangiocarcinoma

2.Pfizer Reports Results of Abrocitinib in P-III JADE MONO-2 Study for Moderate to Severe Atopic Dermatitis

Published: Sept 27, 2019 | Tags: Pfizer, Reports, Results, Abrocitinib, P-III, JADE MONO-2 Study, Moderate, Severe, Atopic Dermatitis

3. Simcere Signs an Exclusive License Agreement with JW Pharmaceutical for an Anti-Gout Drug Candidate URC-102 in China

Published: Sept 27, 2019 | Tags: Simcere, Signs, Exclusive, License Agreement, JW Pharmaceutical, Anti-Gout Drug Candidate, URC-102, China

4. Ieso Launches Eight Billion Minds Digital Initiative Addressing Unmet Mental Health Needs

Published: Sept 26, 2019 | Tags: Ieso, Launches, Eight Billion Minds, Digital Initiative, Addressing, Unmet, Mental Health Needs

5.Medtronic Reports Results of Resolute Onyx DES in Onyx ONE Global Study for High-Bleeding Risk Patients with One-Month DAPT

Published: Sept 26, 2019 | Tags: Medtronic, Reports, Results, Resolute Onyx DES, Onyx ONE Global Study, High-Bleeding Risk, One-Month DAPT

6. Janssen's Darzalex (daratumumab) Combination Therapy Receives FDA's Approval for Frontline Multiple Myeloma

Published: Sept 26, 2019 | Tags: Janssen, Darzalex, daratumumab, Combination Therapy, Receives, FDA, Approval, Frontline Multiple Myeloma

7.AbbVie's Mavyret (glecaprevir/pibrentasvir) Receives FDA's Approval for its Expanded Indication in Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis Across All Genotypes

Published: Sept 26, 2019 | Tags: AbbVie, Mavyret, glecaprevir, pibrentasvir, Receives, FDA, Approval, Expanded Indication, Treatment-Naïve Patients, Chronic Hepatitis C, Compensated Cirrhosis

8. Medtronic to Initiate Clinical Study Evaluating Infuse Bone Graft in TLIF Spine Procedures

Published:  Sept 26, 2019 | Tags: Medtronic, Initiate, Clinical Study, Evaluating, Infuse Bone Graft, TLIF Spine Procedures

9. AstraZeneca and Innate Pharma to Advance Monalizumab in a P-III Study for Head and Neck Cancer

Published: Sept 26, 2019 | Tags: AstraZeneca, Innate Pharma, Advance, Monalizumab, P-III, Study, Head and Neck Cancer

10.Jazz Reports Results of JZP-258 in a P-III Study to Treat Cataplexy and Excessive Daytime Sleepiness in Patients with Narcolepsy

Published: Sept 26, 2019 | Tags: Jazz, Reports, Results, JZP-258, P-III, Treat, Cataplexy, EDS, Narcolepsy

11. Thermo Fisher to Expand its Clinical Trials Capabilities and Collaborates with Frontier to Develop Therapy for HIV

Published: Sept 26, 2019 | Tags: Thermo Fisher, Reports, Expansion, Clinical Trials, Capabilities, Collaborates, Frontier, HIV

12.Abbott'sARCHITECT STAT High Sensitivity Troponin-I Blood Test Receives FDA Clearance to Detect Heart Attacks Faster and Accurately

Published: Sept 25, 2019 | Tags: Abbott, ARCHITECT STAT High Sensitivity Troponin-I Blood Test, Receives, FDA, Clearance, Heart Attacks, Faster, Accurately

13. Takeda Reports Results of Vedolizumab in its First Head-to-Head Biologic Study for Ulcerative Colitis

Published: Sept 25, 2019 | Tags: Takeda, Reports, Results, Vedolizumab, First, Head-to-Head, Biologic Study, Ulcerative Colitis

14.Ethicon Launches Echelon Circular as the First Powered Circular Stapler for Colorectal Gastric and Thoracic Surgery

Published: Sept 24, 2019 | Tags: Ethicon, Launches, Echelon Circular, Powered Circular Stapler, Colorectal, Gastric, Thoracic, Surgery

15. Achillion's Danicopan (ACH-4471) Receives FDA's Breakthrough Therapy Designation for Paroxysmal Nocturnal Hemoglobinuria

Published: Sept 25, 2019 | Tags: Achillion, Danicopan, ACH-4471, Receives, FDA, Breakthrough Therapy Designation, Paroxysmal Nocturnal Hemoglobinuria

16. Bavarian Nordic's Jynneos Vaccine Receives FDA's Approval to Prevent Smallpox and Monkeypox Disease in Adults

Published: Sept 24, 2019 | Tags: Bavarian Nordic, Jynneos Vaccine, Receives, FDA, Approval, Prevent, Smallpox, Monkeypox Disease, Adults

17.Amgen Reports Results of Blincyto (blinatumomab) in Two P-III Studies for Relapsed Acute Lymphoblastic Leukemia in Pediatric Patients

Published: Sept 24, 2019 | Tags: Amgen, Reports, Results, Blincyto, blinatumomab, Relapsed Acute Lymphoblastic Leukemia, Pediatric Patients

18. Pfizer Expands its Collaboration with Flatiron Health to Integrate the Use of Real-World Evidence in Oncology

Published: Sept 24, 2019 | Tags: Pfizer, Expands, Collaboration, Flatiron Health, Integrate, Real-World Evidence, Oncology

19.Biocon Biologics Acquires Pfizer's Research Facility to Expand its Research and Development Footprint

Published: Sept 24, 2019 | Tags: Biocon Biologics, Acquires, Pfizer, Research Facility, Expand, R&D Footprints

20.Aldeyra's ADX-2191 Receives FDA's Fast Track Designation to Prevent Proliferative Vitreoretinopathy

Published: Sept 03, 2019 | Tags: Aldeyra, ADX-2191, Receives, FDA, Fast Track Designation, Prevent, Proliferative Vitreoretinopathy

21.BMS' Opdivo (nivolumab) Receives CHMP Recommendation for Approval of its Four-Week Dosing Schedule

Published: Sept 24, 2019 | Tags: BMS, Opdivo, nivolumab, Receives, CHMP, Recommendation, Approval, Four-Week Dosing Schedule

22. Takeda Collaborates with Evotec to Discover Clinical Candidates for Multiple Therapeutic Areas

Published: Sept 24, 2019 | Tags: Takeda, Collaborates, Evotec, Discover, Clinical Candidates, Multiple Therapeutic Areas

23. Bayer Collaborate with Women's Hospital and Massachusetts General Hospital to Launch Joint Lab Targeting Chronic Lung Diseases

Published: Sept 24, 2019 | Tags: Bayer, Collaborates, Women’s Hospital, Massachusetts General Hospital, Launch, Joint, Chronic Lung Diseases

24. Sandoz Voluntary Recalls Ranitidine Hydrochloride Capsules Due to Elevated Amount of N-Nitrosodimethylamine in the US

Published: Sept 23, 2019 | Tags: Sandoz, Voluntary, Recalls, Ranitidine Hydrochloride, N-Nitrosodimethylamine, US

25. Bayer's Vitrakvi (larotrectinib) Receives EMA's Approval as the First Tumor Agonist in Europe

Published: Sept 23, 2019 | Tags: Bayer, Vitrakvi, larotrectinib, Receives, EMA, Approval, First Tumor Agonist, Europe

26. MSD Collaborates with I-Mab to Evaluate Keytruda + TJC4 for Multiple Cancer Indications

Published: Sept 23, 2019 | Tags: MSD, I-Mab, Enters, Clinical Collaboration, Evaluate, Keytruda, TJC4, Cancer

27.Mallinckrodt Reports Results of StrataGraft Regenerative Tissue in P-III STRATA2016 Study for Deep Partial-thickness Thermal Burns

Published: Sept 23, 2019 | Tags: Mallinckrodt, Reports, Results, StrataGraft Regenerative Tissue, P-III, STRATA2016, Study, Deep Partial-thickness Thermal Burns

28. Celltrion's CT-P13 (biosimilar, infliximab) Receives CHMP's Positive Opinion for its SC Formulation to Treat Rheumatoid Arthritis

Published: Sept 23, 2019 | Tags: Celltrion, CT-P13, biosimilar, infliximab, Receives, CHMP Positive Opinion, SC Formulation, Rheumatoid Arthritis

29. Biogen's Plegridy (peginterferon beta-1a) and Avonex (interferon beta-1a) Receive CHMP's Positive Opinion to Use During Pregnancy and Breastfeeding

Published: Sept 23, 2019 | Tags: Biogen, Plegridy, peginterferon beta-1a, Avonex, interferon beta-1a, Receive, CHMP, Positive Opinion, Pregnancy, Breastfeeding

30.Clovis Oncology Signs a License Agreement with 3B Pharmaceuticals for FAP-Targeted Radiopharmaceutical Program

Published: Sept 23, 2019 | Tags: Clovis Oncology, Signs, License Agreement, 3B Pharmaceuticals, FAP-Targeted Radiopharmaceutical Program

31. Novo Nordisk's Rybelsus (semaglutide) Receives FDA's Approval as the First Oral GLP-1 analog for Type 2 Diabetes

Published: Sept 23, 2019 | Tags: Novo Nordisk, Rybelsus, semaglutide, Receives, FDA, Approval, GLP-1 Analog, Type 2 Diabetes

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions